Skip to main content
SpringerLink
Log in

Implication of Synthetic Biology in Biotherapeutic Engineering

  • Chapter
  • First Online:
Systems and Synthetic Immunology

Abstract

Synthetic biology is an emerging field where biology, computer, chemistry and engineering are reciprocally revisited to manipulate, design, construct and develop new biological entities with novel functionalities. Synthetic biology has been widely used in pharmaceutical, chemical, agricultural and energy industries. It is used to design and build complex circuits inspired by electrical engineering for fast and effective solutions of biomedical challenges including antibiotic resistance, viral infections and cancer. Synthetic biology enables us to modify and reconstruct various cells and their components and even whole organisms precisely. Synthetic biology plays significant roles in biotherapeutic engineering for the development of diagnostics, drug designing, enzymes, tailoring tissues and synthetic organs. In addition, it has been widely used in the design and development of medical therapeutics including drugs, diagnostic devices and biocompatible materials to improve the living standards of individuals. Synthetic biology provides an enthusiastic platform to develop biotherapeutic engineering via providing precise molecular biology tools that allow us to manipulate living cells for beneficial use. In this chapter, we cover a detailed overview of recent advancements in molecular tools and approaches to engineer microbial biotherapeutics using synthetic biology especially in human therapeutics and biomedical engineering.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Andries O, Kitada T, Bodner K, Sanders NN, Weiss R (2015) Synthetic biology devices and circuits for RNA-based ‘smart vaccines’: a propositional review. Expert Rev Vaccines 14(2):313–331

    Article  CAS  Google Scholar 

  2. Benner SA, Sismour AM (2005) Synthetic biology. Nat Rev Genet 6(7):533

    Article  CAS  Google Scholar 

  3. Blijlevens N, Sonis S (2006) Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy-and radiotherapy-induced mucositis. Ann Oncol 18(5):817–826

    Article  Google Scholar 

  4. Chappell J, Watters KE, Takahashi MK, Lucks JB (2015) A renaissance in RNA synthetic biology: new mechanisms, applications and tools for the future. Curr Opin Chem Biol 28:47–56

    Article  CAS  Google Scholar 

  5. Clarke JB (2010) Mechanisms of adverse drug reactions to biologics. In: Adverse drug reactions. Springer, pp 453–474

    Google Scholar 

  6. Doyle MV, Lee MT, Fong S (1985) Comparison of the biological activities of human recombinant interleukin-2 (125) and native interleukin-2. J Biol Response Mod 4(1):96–109

    CAS  PubMed  Google Scholar 

  7. Fischbach MA, Bluestone JA, Lim WA (2013) Cell-based therapeutics: the next pillar of medicine. Sci Transl Med 5(179):179ps177–179ps177

    Article  Google Scholar 

  8. Folcher M, Fussenegger M (2012) Synthetic biology advancing clinical applications. Curr Opin Chem Biol 16(3–4):345–354

    Article  CAS  Google Scholar 

  9. Hays SG, Patrick WG, Ziesack M, Oxman N, Silver PA (2015) Better together: engineering and application of microbial symbioses. Curr Opin Biotechnol 36:40–49

    Article  CAS  Google Scholar 

  10. Hsu E, Osslund T, Nybo R, Chen B-L, Kenney WC, Morris CF, Arakawa T, Narhi LO (2006) Enhanced stability of recombinant keratinocyte growth factor by mutagenesis. Protein Eng Des Sel 19(4):147–153

    Article  CAS  Google Scholar 

  11. Huang L, Huang Y-Y, Mroz P, Tegos GP, Zhiyentayev T, Sharma SK, Lu Z, Balasubramanian T, Krayer M, Ruzié C (2010) Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers. Antimicrob Agents Chemother 54(9):3834–3841

    Article  CAS  Google Scholar 

  12. Ishino T, Wang M, Mosyak L, Tam A, Duan W, Svenson K, Joyce A, O’Hara DM, Lin L, Somers WS (2013) Engineering a monomeric Fc domain modality by N-glycosylation for the half-life extension of biotherapeutics. J Biol Chem 288(23):16529–16537

    Article  CAS  Google Scholar 

  13. Jones LH, McKnight AJ (2013) Biotherapeutics: recent developments using chemical and molecular biology, vol 36. Royal Society of Chemistry, Cambridge

    Book  Google Scholar 

  14. Khalil AS, Collins JJ (2010) Synthetic biology: applications come of age. Nat Rev Genet 11(5):367

    Article  CAS  Google Scholar 

  15. Kim JM (2010) Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium bacteroides ovatus. Gut 59:461–469. Korean J Gastroenterol 56(6):394–396

    Article  Google Scholar 

  16. Li J, Zhu Z (2010) Research and development of next generation of antibody-based therapeutics. Acta Pharmacol Sin 31(9):1198

    Article  CAS  Google Scholar 

  17. Lipsitz YY, Bedford P, Davies AH, Timmins NE, Zandstra PW (2017) Achieving efficient manufacturing and quality assurance through synthetic cell therapy design. Cell Stem Cell 20(1):13–17

    Article  CAS  Google Scholar 

  18. Love KR, Dalvie NC, Love JC (2018) The yeast stands alone: the future of protein biologic production. Curr Opin Biotechnol 53:50–58

    Article  CAS  Google Scholar 

  19. Lu TK, Collins JJ (2009) Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc Natl Acad Sci 106(12):4629–4634

    Article  CAS  Google Scholar 

  20. Mimee M, Citorik RJ, Lu TK (2016) Microbiome therapeutics—advances and challenges. Adv Drug Deliv Rev 105:44–54

    Article  CAS  Google Scholar 

  21. Mohammad T, Hassan MI (2018a) Genome microbiology for synthetic applications. In: Synthetic biology. Springer, pp 75–86

    Google Scholar 

  22. Mohammad T, Hassan MI (2018b) Modern approaches in synthetic biology: genome editing, quorum sensing, and microbiome engineering. In: Synthetic biology. Springer, pp 189–205

    Google Scholar 

  23. Nielsen J, Keasling JD (2011) Synergies between synthetic biology and metabolic engineering. Nat Biotechnol 29(8):693

    Article  CAS  Google Scholar 

  24. O’Rourke E, Drummond R, Creasey A (1984) Binding of 125I-labeled recombinant beta interferon (IFN-beta Ser17) to human cells. Mol Cell Biol 4(12):2745–2749

    Article  Google Scholar 

  25. Ozdemir T, Fedorec AJ, Danino T, Barnes CP (2018) Synthetic biology and engineered live biotherapeutics: toward increasing system complexity. Cell Syst 7(1):5–16

    Article  CAS  Google Scholar 

  26. Pedrolli DB, Ribeiro NV, Squizato PN, de Jesus VN, Cozetto DA, Unesp at iGEM TA (2018) Engineering microbial living therapeutics: the synthetic biology toolbox. Trend Biotechnol

    Google Scholar 

  27. Shahid N, Daniell H (2016) Plant-based oral vaccines against zoonotic and non-zoonotic diseases. Plant Biotechnol J 14(11):2079–2099

    Article  Google Scholar 

  28. Skwarczynski M, Toth I (2016) Peptide-based synthetic vaccines. Chem Sci 7(2):842–854

    Article  CAS  Google Scholar 

  29. Yu X, Marshall MJ, Cragg MS, Crispin M (2017) Improving antibody-based cancer therapeutics through glycan engineering. BioDrugs 31(3):151–166

    Article  CAS  Google Scholar 

  30. Zhang Y-HP, Sun J, Ma Y (2017) Biomanufacturing: history and perspective. J Ind Microbiol Biotechnol 44(4–5):773–784

    Article  CAS  Google Scholar 

  31. Zhong X, Neumann P, Corbo M, Loh E (2011) Recent advances in biotherapeutics drug discovery and development. In: Drug discovery and development-present and future. IntechOpen

    Google Scholar 

Download references

Conflict of Interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India

    Taj Mohammad, Rashmi Dahiya & Md. Imtaiyaz Hassan

Authors
  1. Taj Mohammad
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rashmi Dahiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Md. Imtaiyaz Hassan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Md. Imtaiyaz Hassan .

Editor information

Editors and Affiliations

  1. National Centre for Cell Science, Pune, Maharashtra, India

    Shailza Singh

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mohammad, T., Dahiya, R., Hassan, M.I. (2020). Implication of Synthetic Biology in Biotherapeutic Engineering. In: Singh, S. (eds) Systems and Synthetic Immunology . Springer, Singapore. https://doi.org/10.1007/978-981-15-3350-1_9

Download citation

Publish with us

Policies and ethics

Search

Navigation